India's Dr Reddy's beats quarterly profit estimate
Yesterday 13:07
India's Dr Reddy's beats quarterly profit estimate Oct 23 (Reuters) - Indian drugmaker Dr Reddy's Laboratories REDY.NS reported a better-than-expected quarterly profit on Friday, as domestic demand helped cushion the slowdown in its key US market.
Consolidated net profit after tax fell to 9.25 billion rupees ($97.43 million) in the quarter ended September 30, from 13.47 billion rupees a year ago. Analysts, on average, had estimated a profit of 7.49 billion rupees, according to data compiled by LSEG.
($1 = 94.9400 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru; Editing by Shilpi Majumdar)
((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption